Listed

ProPhase Labs, Inc.: Form 10-K for the period ended Dec 31, 2017

Filed with the SEC on Mar 28, 2018 and accepted by EDGAR at Mar 28, 2018, 20:47 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue12 months2017-01-01 to 2017-12-31$7.9mus-gaap:CostOfGoodsAndServicesSold
Gross profit12 months2017-01-01 to 2017-12-31$1.9mus-gaap:GrossProfit
Research and development12 months2017-01-01 to 2017-12-31$431.0kus-gaap:ResearchAndDevelopmentExpense
Interest expense12 months2017-01-01 to 2017-12-31$54.0kus-gaap:InterestExpense
Income tax12 months2017-01-01 to 2017-12-31−$18.0mus-gaap:IncomeTaxExpenseBenefit
Net income12 months2017-01-01 to 2017-12-31$41.8mus-gaap:NetIncomeLoss
Diluted EPS12 months2017-01-01 to 2017-12-31$2.67us-gaap:EarningsPerShareDiluted
Basic EPS12 months2017-01-01 to 2017-12-31$2.69us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2017-01-01 to 2017-12-3115,696 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2017-01-01 to 2017-12-31−$2.8mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2017-01-01 to 2017-12-31$208.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases12 months2017-01-01 to 2017-12-31$16.3mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2017-12-31$3.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-12-31$28.9mus-gaap:AssetsCurrent
Total assetsAt period end2017-12-31$34.2mus-gaap:Assets
Current liabilitiesAt period end2017-12-31$1.1mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2017-12-31$33.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-18-004041. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.